Drug
Dextromethorphan Hydrobromide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Toxicity | 79 | 40.3 | 41.3 | signal |
| 2 | Folliculitis | 43 | 29.3 | 29.7 | signal |
| 3 | Serotonin Syndrome | 78 | 28.7 | 29.4 | signal |
| 4 | Helicobacter Infection | 38 | 26.2 | 26.5 | signal |
| 5 | Pemphigus | 41 | 23.2 | 23.5 | signal |
| 6 | Drug Abuse | 272 | 22.8 | 25.0 | signal |
| 7 | Autoimmune Disorder | 31 | 22.7 | 23.0 | signal |
| 8 | Hand Deformity | 36 | 19.3 | 19.5 | signal |
| 9 | Bursitis | 32 | 18.6 | 18.8 | signal |
| 10 | Joint Range Of Motion Decreased | 35 | 18.4 | 18.6 | signal |
| 11 | Respiratory Arrest | 72 | 18.2 | 18.6 | signal |
| 12 | Mydriasis | 31 | 17.0 | 17.1 | signal |
| 13 | Completed Suicide | 179 | 14.9 | 15.8 | signal |
| 14 | Pericarditis | 35 | 14.7 | 14.9 | signal |
| 15 | Fibromyalgia | 47 | 13.6 | 13.8 | signal |
| 16 | Liver Injury | 44 | 12.8 | 12.9 | signal |
| 17 | Sciatica | 28 | 12.4 | 12.5 | signal |
| 18 | Glossodynia | 38 | 11.9 | 12.1 | signal |
| 19 | Intentional Drug Misuse | 36 | 11.9 | 12.0 | signal |
| 20 | Irritable Bowel Syndrome | 36 | 11.8 | 11.9 | signal |
| 21 | Synovitis | 30 | 11.7 | 11.8 | signal |
| 22 | Poisoning | 19 | 10.6 | 10.6 | signal |
| 23 | Cardio-respiratory Arrest | 61 | 10.2 | 10.3 | signal |
| 24 | Pulmonary Congestion | 19 | 10.1 | 10.1 | signal |
| 25 | Toxicity To Various Agents | 237 | 9.9 | 10.7 | signal |
| 26 | Interstitial Lung Disease | 68 | 9.9 | 10.1 | signal |
| 27 | Intentional Overdose | 86 | 9.5 | 9.7 | signal |
| 28 | Disseminated Intravascular Coagulation | 19 | 9.4 | 9.5 | signal |
| 29 | Obesity | 21 | 9.2 | 9.3 | signal |
| 30 | Lower Limb Fracture | 25 | 9.2 | 9.2 | signal |
| 31 | Erythema Multiforme | 12 | 9.0 | 9.1 | signal |
| 32 | Liver Disorder | 57 | 9.0 | 9.2 | signal |
| 33 | Type 2 Diabetes Mellitus | 41 | 8.5 | 8.6 | signal |
| 34 | Paranoia | 21 | 8.5 | 8.5 | signal |
| 35 | Accidental Overdose | 44 | 8.4 | 8.5 | signal |
| 36 | Exposure During Pregnancy | 73 | 8.2 | 8.4 | signal |
| 37 | Euphoric Mood | 12 | 8.2 | 8.2 | signal |
| 38 | Contraindicated Product Administered | 34 | 7.9 | 8.0 | signal |
| 39 | Impaired Healing | 37 | 7.9 | 8.0 | signal |
| 40 | Wound | 31 | 7.8 | 7.9 | signal |
| 41 | Wound Infection | 12 | 7.7 | 7.8 | signal |
| 42 | Psoriatic Arthropathy | 44 | 7.7 | 7.8 | signal |
| 43 | Muscle Rigidity | 13 | 7.6 | 7.6 | signal |
| 44 | Road Traffic Accident | 45 | 7.5 | 7.6 | signal |
| 45 | Hypercholesterolaemia | 10 | 7.3 | 7.3 | signal |
| 46 | Oesophagitis | 11 | 7.0 | 7.1 | signal |
| 47 | Pulmonary Fibrosis | 19 | 7.0 | 7.0 | signal |
| 48 | Delirium | 34 | 6.9 | 7.0 | signal |
| 49 | Oedema | 53 | 6.9 | 7.0 | signal |
| 50 | Rebound Effect | 11 | 6.8 | 6.8 | signal |
| 51 | Gait Inability | 31 | 6.6 | 6.6 | signal |
| 52 | Caesarean Section | 11 | 6.6 | 6.6 | signal |
| 53 | Systemic Lupus Erythematosus | 33 | 6.5 | 6.6 | signal |
| 54 | Hepatic Function Abnormal | 34 | 6.4 | 6.5 | signal |
| 55 | Cardiac Arrest | 75 | 6.3 | 6.5 | signal |
| 56 | Therapy Non-responder | 40 | 6.3 | 6.4 | signal |
| 57 | Intentional Product Misuse | 76 | 6.1 | 6.3 | signal |
| 58 | Injury | 61 | 6.0 | 6.2 | signal |
| 59 | Drug Effect Less Than Expected | 12 | 6.0 | 6.0 | signal |
| 60 | Drug Eruption | 15 | 6.0 | 6.0 | signal |
| 61 | Altered State Of Consciousness | 18 | 5.8 | 5.9 | signal |
| 62 | Respiratory Depression | 10 | 5.7 | 5.7 | signal |
| 63 | Sleep Disorder | 57 | 5.7 | 5.8 | signal |
| 64 | Sinus Tachycardia | 11 | 5.4 | 5.5 | signal |
| 65 | Prescribed Overdose | 15 | 5.4 | 5.5 | signal |
| 66 | Inflammation | 39 | 5.3 | 5.4 | signal |
| 67 | Pneumothorax | 12 | 5.3 | 5.3 | signal |
| 68 | Myoclonus | 9 | 5.3 | 5.3 | signal |
| 69 | Sudden Death | 8 | 5.2 | 5.3 | signal |
| 70 | Blood Cholesterol Increased | 34 | 5.1 | 5.2 | signal |
| 71 | Mobility Decreased | 52 | 5.1 | 5.2 | signal |
| 72 | Stomatitis | 44 | 5.1 | 5.1 | signal |
| 73 | Pneumonia Aspiration | 18 | 5.1 | 5.1 | signal |
| 74 | Lung Disorder | 35 | 5.0 | 5.1 | signal |
| 75 | Night Sweats | 23 | 5.0 | 5.0 | signal |
| 76 | Infusion Related Reaction | 47 | 5.0 | 5.0 | signal |
| 77 | Wheezing | 42 | 5.0 | 5.0 | signal |
| 78 | Pneumocystis Jirovecii Pneumonia | 7 | 4.9 | 4.9 | signal |
| 79 | Unresponsive To Stimuli | 18 | 4.9 | 4.9 | signal |
| 80 | Bronchospasm | 10 | 4.9 | 4.9 | signal |
| 81 | Coma | 33 | 4.8 | 4.9 | signal |
| 82 | Pregnancy | 14 | 4.8 | 4.9 | signal |
| 83 | Oral Candidiasis | 9 | 4.8 | 4.9 | signal |
| 84 | Suicide Attempt | 42 | 4.8 | 4.9 | signal |
| 85 | Depressed Level Of Consciousness | 27 | 4.8 | 4.8 | signal |
| 86 | Drug-induced Liver Injury | 21 | 4.8 | 4.8 | signal |
| 87 | Dry Mouth | 55 | 4.8 | 4.8 | signal |
| 88 | Ataxia | 8 | 4.7 | 4.7 | signal |
| 89 | Shock | 15 | 4.6 | 4.6 | signal |
| 90 | Laryngitis | 7 | 4.5 | 4.5 | signal |
| 91 | Ill-defined Disorder | 39 | 4.5 | 4.5 | signal |
| 92 | Red Blood Cell Sedimentation Rate Increased | 7 | 4.4 | 4.4 | signal |
| 93 | Arthropathy | 35 | 4.4 | 4.4 | signal |
| 94 | Drug Level Increased | 10 | 4.2 | 4.2 | signal |
| 95 | Dry Throat | 6 | 4.1 | 4.1 | signal |
| 96 | Hepatic Enzyme Increased | 40 | 4.1 | 4.2 | signal |
| 97 | Sinusitis | 60 | 4.1 | 4.2 | signal |
| 98 | Drug Interaction | 91 | 4.0 | 4.1 | signal |
| 99 | Joint Dislocation | 6 | 4.0 | 4.0 | signal |
| 100 | Osteoarthritis | 24 | 4.0 | 4.0 | signal |
| 101 | Abscess | 9 | 4.0 | 4.0 | signal |
| 102 | Blood Lactate Dehydrogenase Increased | 9 | 4.0 | 4.0 | signal |
| 103 | Brain Oedema | 7 | 3.9 | 3.9 | signal |
| 104 | Lower Respiratory Tract Infection | 25 | 3.9 | 3.9 | signal |
| 105 | Withdrawal Syndrome | 23 | 3.8 | 3.8 | signal |
| 106 | Urinary Retention | 18 | 3.8 | 3.8 | signal |
| 107 | Poisoning Deliberate | 5 | 3.8 | 3.8 | signal |
| 108 | Anorexia | 7 | 3.7 | 3.8 | signal |
| 109 | Arteriosclerosis | 5 | 3.7 | 3.7 | signal |
| 110 | Agitation | 39 | 3.7 | 3.7 | signal |
| 111 | Therapeutic Product Effect Incomplete | 37 | 3.7 | 3.7 | signal |
| 112 | Product Taste Abnormal | 7 | 3.6 | 3.7 | signal |
| 113 | Blister | 29 | 3.6 | 3.6 | signal |
| 114 | Eosinophilia | 9 | 3.6 | 3.6 | signal |
| 115 | Discomfort | 31 | 3.6 | 3.6 | signal |
| 116 | Musculoskeletal Pain | 27 | 3.6 | 3.6 | signal |
| 117 | Asthma | 57 | 3.6 | 3.6 | signal |
| 118 | Psychotic Disorder | 15 | 3.6 | 3.6 | signal |
| 119 | Covid-19 Pneumonia | 6 | 3.5 | 3.5 | signal |
| 120 | Prescribed Underdose | 10 | 3.5 | 3.5 | signal |
| 121 | Premature Delivery | 8 | 3.5 | 3.5 | signal |
| 122 | Aggression | 25 | 3.5 | 3.5 | signal |
| 123 | Coordination Abnormal | 7 | 3.5 | 3.5 | signal |
| 124 | Emphysema | 5 | 3.5 | 3.5 | signal |
| 125 | Muscle Spasticity | 6 | 3.4 | 3.4 | signal |
| 126 | Cytomegalovirus Infection | 8 | 3.4 | 3.4 | signal |
| 127 | Pulmonary Arterial Hypertension | 7 | 3.4 | 3.4 | signal |
| 128 | Hallucination, Visual | 10 | 3.3 | 3.3 | signal |
| 129 | Joint Swelling | 57 | 3.3 | 3.4 | signal |
| 130 | Face Oedema | 8 | 3.3 | 3.3 | signal |
| 131 | Retching | 10 | 3.3 | 3.3 | signal |
| 132 | Drug Reaction With Eosinophilia And Systemic Symptoms | 12 | 3.3 | 3.3 | signal |
| 133 | Hip Arthroplasty | 7 | 3.2 | 3.2 | signal |
| 134 | Delusion | 7 | 3.2 | 3.2 | signal |
| 135 | Foot Deformity | 5 | 3.2 | 3.2 | signal |
| 136 | Neutrophil Count Decreased | 18 | 3.1 | 3.1 | signal |
| 137 | Sleep Disorder Due To A General Medical Condition | 7 | 3.0 | 3.0 | signal |
| 138 | Anaphylactic Shock | 11 | 3.0 | 3.0 | signal |
| 139 | Adverse Drug Reaction | 37 | 2.9 | 2.9 | signal |
| 140 | Overdose | 89 | 2.9 | 2.9 | signal |
| 141 | Decreased Immune Responsiveness | 4 | 2.9 | 2.9 | no signal |
| 142 | Stevens-johnson Syndrome | 9 | 2.8 | 2.8 | signal |
| 143 | Ischaemic Stroke | 7 | 2.7 | 2.7 | signal |
| 144 | Blood Creatine Phosphokinase Increased | 11 | 2.6 | 2.6 | signal |
| 145 | Pharyngitis Streptococcal | 4 | 2.6 | 2.6 | no signal |
| 146 | Acute Hepatic Failure | 5 | 2.6 | 2.6 | no signal |
| 147 | Disability | 7 | 2.5 | 2.5 | signal |
| 148 | Status Epilepticus | 4 | 2.5 | 2.5 | no signal |
| 149 | Metastases To Lung | 4 | 2.4 | 2.4 | no signal |
| 150 | Multi-organ Failure | 6 | 2.4 | 2.4 | no signal |
| 151 | Therapeutic Product Effect Decreased | 15 | 2.4 | 2.4 | signal |
| 152 | Medication Error | 18 | 2.3 | 2.3 | signal |
| 153 | Tooth Extraction | 4 | 2.2 | 2.3 | no signal |
| 154 | Personality Change | 3 | 2.2 | 2.2 | no signal |
| 155 | Cytokine Release Syndrome | 6 | 2.2 | 2.2 | no signal |
| 156 | Hallucination, Auditory | 5 | 2.2 | 2.2 | no signal |
| 157 | Metastases To Central Nervous System | 4 | 2.2 | 2.2 | no signal |
| 158 | Rheumatoid Arthritis | 35 | 2.2 | 2.2 | signal |
| 159 | Palmar-plantar Erythrodysaesthesia Syndrome | 7 | 2.1 | 2.1 | no signal |
| 160 | Intentional Self-injury | 6 | 2.1 | 2.1 | no signal |
| 161 | Maternal Exposure During Pregnancy | 26 | 2.1 | 2.1 | signal |
| 162 | Malignant Neoplasm Progression | 30 | 2.1 | 2.1 | signal |
| 163 | Knee Arthroplasty | 6 | 2.0 | 2.0 | no signal |
| 164 | Abnormal Behaviour | 11 | 1.9 | 1.9 | no signal |
| 165 | Sedation | 7 | 1.9 | 1.9 | no signal |
| 166 | Myocarditis | 3 | 1.9 | 1.9 | no signal |
| 167 | Neuroleptic Malignant Syndrome | 3 | 1.8 | 1.8 | no signal |
| 168 | Incorrect Product Administration Duration | 5 | 1.7 | 1.7 | no signal |
| 169 | Libido Decreased | 3 | 1.7 | 1.7 | no signal |
| 170 | Expired Product Administered | 8 | 1.7 | 1.7 | no signal |
| 171 | Drug Exposure During Pregnancy | 6 | 1.2 | 1.2 | no signal |
| 172 | Premature Baby | 5 | 1.2 | 1.2 | no signal |
| 173 | Product Complaint | 4 | 1.1 | 1.1 | no signal |
| 174 | Therapeutic Response Shortened | 5 | 1.1 | 1.1 | no signal |
| 175 | Drug Dependence | 21 | 0.9 | 0.9 | no signal |
| 176 | Pharmaceutical Product Complaint | 3 | 0.8 | 0.8 | no signal |